Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
ECG 10s (CHRIS baseline)
x0ec121b
R-Amplitude, II
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec121c
R-Amplitude, III
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec121g
R-Amplitude, V1
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec121h
R-Amplitude, V2
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec121i
R-Amplitude, V3
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec121j
R-Amplitude, V4
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec121k
R-Amplitude, V5
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec121l
R-Amplitude, V6
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec121f
R-Amplitude, aVF
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec121e
R-Amplitude, aVL
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec121d
R-Amplitude, aVR
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec128a
S'-Amplitude, I
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec128b
S'-Amplitude, II
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec128c
S'-Amplitude, III
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec128g
S'-Amplitude, V1
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec128h
S'-Amplitude, V2
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec128i
S'-Amplitude, V3
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec128j
S'-Amplitude, V4
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec128k
S'-Amplitude, V5
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec128l
S'-Amplitude, V6
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec128f
S'-Amplitude, aVF
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec128e
S'-Amplitude, aVL
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec128d
S'-Amplitude, aVR
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec126a
S-Amplitude, I
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec126b
S-Amplitude, II
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec126c
S-Amplitude, III
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec126g
S-Amplitude, V1
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec126h
S-Amplitude, V2
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec126i
S-Amplitude, V3
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec126j
S-Amplitude, V4
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec126k
S-Amplitude, V5
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec126l
S-Amplitude, V6
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec126f
S-Amplitude, aVF
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec126e
S-Amplitude, aVL
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec126d
S-Amplitude, aVR
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec137a
T-Amplitude, I
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec137b
T-Amplitude, II
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec137c
T-Amplitude, III
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec137g
T-Amplitude, V1
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec137h
T-Amplitude, V2
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec137i
T-Amplitude, V3
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec137j
T-Amplitude, V4
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec137k
T-Amplitude, V5
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec137l
T-Amplitude, V6
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec137f
T-Amplitude, aVF
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec137e
T-Amplitude, aVL
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec137d
T-Amplitude, aVR
Voltage amplitude of the peak of T wave, expressed in milliVolts, measured in lead aVR
Float
Physical activity (CHRIS baseline)
x0ip07
Walking MET-minutes/week
Walking MET-minutes/week
Float
Anthropometry (CHRIS baseline)
x0an02
Weight
Weight
Float
Baseline information (CHRIS COVID-19)
ccbq25
Self-reported weight
What is your weight?
Float
Blood measurements (CHRIS baseline)
x0lp39
White Blood Cell Count (WBC)
White Blood Cell Count (WBC)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt003
alpha-AAA
alpha-Aminoadipic acid
Float
Blood measurements (CHRIS baseline)
x0lp86a
estimated Glomerular filtration rate (eGFR) CKDEPI crea
estimated Glomerular filtration rate (eGFR) CKDEPI crea
Float
Blood measurements (CHRIS baseline)
x0lp86b
estimated Glomerular filtration rate (eGFR) MDRD4
estimated Glomerular filtration rate (eGFR) MDRD4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt072
lysoPC a C14:0
lysoPhosphatidylcholine acyl C14:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt073
lysoPC a C16:0
lysoPhosphatidylcholine acyl C16:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt074
lysoPC a C16:1
lysoPhosphatidylcholine acyl C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt075
lysoPC a C17:0
lysoPhosphatidylcholine acyl C17:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt076
lysoPC a C18:0
lysoPhosphatidylcholine acyl C18:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt077
lysoPC a C18:1
lysoPhosphatidylcholine acyl C18:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt078
lysoPC a C18:2
lysoPhosphatidylcholine acyl C18:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt079
lysoPC a C20:3
lysoPhosphatidylcholine acyl C20:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt080
lysoPC a C20:4
lysoPhosphatidylcholine acyl C20:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt081
lysoPC a C24:0
lysoPhosphatidylcholine acyl C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt082
lysoPC a C26:0
lysoPhosphatidylcholine acyl C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt083
lysoPC a C26:1
lysoPhosphatidylcholine acyl C26:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt084
lysoPC a C28:0
lysoPhosphatidylcholine acyl C28:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt085
lysoPC a C28:1
lysoPhosphatidylcholine acyl C28:1
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec42
Maximum Heart Rate
maximum HR
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec43
Mean Heart Rate
mean HR
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec41
Minimum Heart Rate
minimum HR
Float
Mitochondrial DNA copy number (CHRIS baseline)
x0mt01
mtDNA copy number
mtDNA copy number
Float
Mitochondrial DNA copy number (CHRIS baseline)
x0mt01a
mtDNA copy number (2nd measurement)
mtDNA copy number (2nd measurement)
Float
Heart rate variability (CHRIS baseline)
x0ec219
pNN50
pNN50: NN50 divided by the total number of RR intervals
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt031
t4-OH-Pro
trans-4-Hydroxyproline
Float
Vaccination status (CHRIS COVID-19)
ccva22
Date of SARS-CoV-2 vaccination
Date of SARS-CoV-2 vaccination
Date
Vaccination status (CHRIS COVID-19)
ccvadate
Date of SARS-CoV-2 vaccination status assessment
Date of SARS-CoV-2 vaccination status assessment
Date
Mitochondrial DNA copy number (CHRIS baseline)
x0mt06
Date of experiment
Date of experiment
Date
Mitochondrial DNA copy number (CHRIS baseline)
x0mt06a
Date of experiment (2nd measurement)
Date of experiment (2nd measurement)
Date
Longitudinal information (CHRIS COVID-19)
cclqldate
Date of last CC19 questionnaire
Date of last CHRIS COVID-19 questionnaire
Date
Movement disorder examination (CHRIS baseline)
x0_examddp
Date of participation
Date of participation at Movement Disorder Deep Phenotyping
Date
Biochemical traits (CHRIS COVID-19)
cc_examd
Date of sample collection
Date of sample collection
Date
Complement system (CHRIS baseline)
x0cs05
Date of the experiment
Date of the experiment
Date
Longitudinal information (CHRIS COVID-19)
cclq07
Date of first symptom appearance
On approximately which date did the first symptoms appear?
Date
Baseline information (CHRIS COVID-19)
ccbqdate
Submission date of CC19 baseline questionnaire
Submission date of CHRIS COVID-19 baseline questionnaire
Date
Longitudinal information (CHRIS COVID-19)
cclqdate
Submission date of CC19 questionnaire
Submission date of CHRIS COVID-19 questionnaire
Date
Longitudinal information (CHRIS COVID-19)
cclq17a
Date first Covid-19 vaccination
When did you receive the first dose of vaccine?
Date
Longitudinal information (CHRIS COVID-19)
cclq17b
Date last Covid-19 vaccination
When did you receive the last dose of vaccine? (same date as first dose in case of single dose vaccines)
Date
Blood measurements (CHRIS baseline)
x0lp51h
ANA observation
ANA observation
Character
Blood measurements (CHRIS baseline)
x0lp51i
ANA pattern2
ANA pattern2
Character
Blood measurements (CHRIS baseline)
x0lp51j
ANA pattern3
ANA pattern3
Character
Drug intake (CHRIS baseline)
x0dd05
ATC 2nd level of classification
ATC 2nd level of classification - therapeutic subgroup
Character
Drug intake (CHRIS baseline)
x0dd06
Active compound
Active compound name (Drug)
Character
Alcohol (CHRIS baseline)
x0alnote
Alcohol notes
Alcohol notes
Character
Pain pressure threshold (CHRIS baseline)
x0amnote
Algometer notes
Algometer notes
Character
Drug intake (CHRIS baseline)
x0dd03
Clean ATC code
Anatomical Therapeutic Chemical classification system (ATC) code
Character
ECG 10s (CHRIS baseline)
x0ec149
Automatic diagnosis by the software
Automatic diagnosis with main findings, given by the software
Character
ECG 10s (CHRIS baseline)
x0ec150
Automatic diagnosis in English
Automatic diagnosis with main findings, given by the software, translated into English
Character
Birth (CHRIS baseline)
x0binote
Birth notes
Birth notes
Character
Birth (CHRIS baseline)
x0bin1
Birth notes (birth weight)
Birth notes (birth weight)
Character
Previous
1
13
14
15
16
17
43
Next